Symptom Management After Breast Cancer Surgery

Completed · Phase 4 · Has a placebo group

Conditions studied: Neuropathic Pain, Postmastectomy Pain

In brief

This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women who wear the lidocaine patch will report a decrease in pain and decreased interference with function compared to women who wear the placebo patch.

Key facts

Study ID

NCT00686127

Run by

University of California, San Francisco

People needed

21

Starts

2003-09-01

Expected to finish

2007-12-01

Last updated by the study team

2018-06-28

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Adult women >18 years who develop neuropathic pain in the breast scar area and/or ipsilateral arm following breast cancer surgery
• Has a healed incision(s)
• Has no recurrent disease in the painful area
• Is able to read, write and understand English

You may not qualify if…

• Presence of another type of pain that is more severe than the neuropathic pain
• Use of an opioid analgesic of greater than 60 mg codeine/day
• Is actively trying to become pregnant
• Has a medical contraindication to the use of lidocaine
• Has an allergy to lidocaine
• Is taking a coanalgesic for neuropathic pain.

Where it is running

• UCSF Comprehensive Cancer Center — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.